| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.76B | 32.70B | 28.91B | 32.24B | 35.03B | 28.68B |
| Gross Profit | 10.87B | 9.69B | 7.96B | 10.29B | 10.25B | 8.41B |
| EBITDA | 9.00B | 8.88B | 6.91B | 9.12B | 9.64B | 6.69B |
| Net Income | 4.16B | 4.04B | 3.27B | 4.73B | 5.00B | 3.31B |
Balance Sheet | ||||||
| Total Assets | 58.64B | 59.96B | 54.64B | 52.84B | 49.87B | 45.32B |
| Cash, Cash Equivalents and Short-Term Investments | 12.59B | 13.05B | 7.89B | 8.09B | 9.92B | 7.72B |
| Total Debt | 3.12B | 3.53B | 4.92B | 3.58B | 2.25B | 3.00B |
| Total Liabilities | 13.48B | 13.82B | 11.01B | 11.44B | 10.74B | 10.30B |
| Stockholders Equity | 44.39B | 45.44B | 42.98B | 40.83B | 38.65B | 34.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.56B | -366.50M | -789.48M | 3.51B | 409.71M |
| Operating Cash Flow | 0.00 | 8.60B | 4.37B | 4.73B | 5.84B | 4.80B |
| Investing Cash Flow | 0.00 | -298.37M | -4.13B | -4.85B | -1.04B | -3.98B |
| Financing Cash Flow | 0.00 | -3.13B | -476.17M | -1.56B | -1.83B | -648.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥64.55B | 10.24 | ― | 2.01% | -1.66% | -29.18% | |
77 Outperform | ¥64.28B | 13.15 | ― | 3.33% | 3.03% | 28.27% | |
77 Outperform | ¥84.40B | 16.84 | 10.57% | 1.82% | 15.12% | 40.72% | |
76 Outperform | ¥70.48B | 5.97 | ― | 3.14% | 3.55% | 214.69% | |
75 Outperform | ¥65.88B | 14.08 | ― | 4.18% | 0.32% | -43.10% | |
70 Outperform | ¥49.27B | 9.71 | ― | 4.58% | 0.10% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Osaka Organic Chemical Industry Ltd. reported a significant increase in its financial performance for the third quarter of the fiscal year ending November 30, 2025. The company achieved a 12.3% year-on-year increase in net sales, reaching 26,699 million yen, driven by growth across its chemical products, electronic materials, and specialty chemicals businesses. Operating profit surged by 54.5% to 4,631 million yen, attributed to a decrease in depreciation and increased sales. Despite a gradual economic recovery, the company remains cautious due to uncertainties in global trade policies and geopolitical issues.
The most recent analyst rating on (JP:4187) stock is a Buy with a Yen3208.00 price target. To see the full list of analyst forecasts on Osaka Organic Chemical Industry Ltd. stock, see the JP:4187 Stock Forecast page.
Osaka Organic Chemical Industry Ltd. reported significant growth in its financial results for the nine months ending August 31, 2025, with net sales increasing by 12.3% and operating profit by 54.5% compared to the previous year. The company has also revised its dividend forecast upwards, reflecting its strong financial performance and strategic expansion, which includes the establishment of a new subsidiary in Korea, potentially enhancing its market position and stakeholder value.
The most recent analyst rating on (JP:4187) stock is a Buy with a Yen3208.00 price target. To see the full list of analyst forecasts on Osaka Organic Chemical Industry Ltd. stock, see the JP:4187 Stock Forecast page.
Osaka Organic Chemical Industry Ltd. has finalized a joint venture agreement with SHIN-NAKAMURA CHEMICAL Co., Ltd. to establish Visnex Chemicals Corporation in New Jersey, USA. This joint venture aims to enhance the sales of specialty acrylic acid esters in the U.S. market, aligning with the company’s medium-term management plan, Progress & Development 2030. The joint venture will be 70% owned by Osaka Organic Chemical Industry Ltd. and 30% by SHIN-NAKAMURA CHEMICAL Co., Ltd., with an expected negligible impact on the company’s financial results for the fiscal year ending November 30, 2025.
The most recent analyst rating on (JP:4187) stock is a Buy with a Yen3208.00 price target. To see the full list of analyst forecasts on Osaka Organic Chemical Industry Ltd. stock, see the JP:4187 Stock Forecast page.